| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 2,663,000 | 2,353,000 | 2,150,000 | 2,269,000 | | Cost of Revenue | 2,010,000 | 1,947,000 | 1,993,000 | 1,947,000 | | | Gross Profit | 653,000 | 406,000 | 157,000 | 322,000 | | | Operating Expenses | | Research Development | 208,000 | 215,000 | 243,000 | 235,000 | | Selling General and Administrative | 106,000 | 113,000 | 134,000 | 142,000 | | Non Recurring | 110,000 | 84,000 | 25,000 | 2,368,000 | | Others | 8,000 | 14,000 | 13,000 | 14,000 | | | | Total Operating Expenses | 432,000 | 426,000 | 415,000 | 2,759,000 | | | | Operating Income or Loss | 221,000 | (20,000) | (258,000) | (2,437,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,000 | 5,000 | 4,000 | (9,000) | | Earnings Before Interest And Taxes | 225,000 | (15,000) | (254,000) | (2,446,000) | | Interest Expense | 45,000 | 39,000 | 35,000 | 30,000 | | Income Before Tax | 180,000 | (54,000) | (289,000) | (2,476,000) | | Income Tax Expense | 1,000 | 27,000 | (16,000) | 316,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 179,000 | (81,000) | (273,000) | (2,792,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 179,000 | (81,000) | (273,000) | (2,792,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $179,000 | ($81,000) | ($273,000) | ($2,792,000) |
|
1.48% Nasdaq 
Income Statement
